Sort
16,300 grants matching “fatty liver disease”
Antihypertensive Effect of Food-Origin Isothiocyanate Soluble Epoxide Hydrolase Inhibitors
$121,986Fawzy Elbarbry · Pacific University · R16 · FY2023 · GM
Coronary artery cross-sectional area and cardiovascular risk in South Asians
$121,887Alka M Kanaya · University Of California, San Francisco · K24 · FY2021 · HL
Developmental origins of dermal adipose tissue
$121,875David Michael Merrick · University Of Pennsylvania · R56 · FY2025 · DK
Genomic Determinants of Nonalcoholic Fatty Liver Disease
$121,770University Of California San Francisco · K08 · FY2004 · DK
Gender Effects of HIV and HCV on lipodystrophy, glucose disorders, and steatosis
$121,770Phyllis C Tien · University Of California, San Francisco · K23 · FY2009 · AI
Gender Effects of HIV and HCV on lipodystrophy, glucose disorders, and steatosis
$121,770Phyllis C Tien · University Of California, San Francisco · K23 · FY2008 · AI
Gender Effects of HIV and HCV on lipodystrophy, glucose disorders, and steatosis
$121,770Phyllis C Tien · University Of California, San Francisco · K23 · FY2007 · AI
Genomic Determinants of Nonalcoholic Fatty Liver Disease
$121,770Raphael B Merriman · University Of California, San Francisco · K08 · FY2006 · DK
Genomic Determinants of Nonalcoholic Fatty Liver Disease
$121,770University Of California San Francisco · K08 · FY2003 · DK
Community Engagement Core
$121,741Lauren Heberle · University Of Louisville · P42 · FY2024 · ES
Insulin Resistance in HCV Infection
$121,674University Of California San Francisco · K23 · FY2005 · DK
Insulin Resistance in HCV Infection
$121,674Mandana Khalili · University Of California, San Francisco · K23 · FY2006 · DK
Insulin Resistance in HCV Infection
$121,674University Of California San Francisco · K23 · FY2002 · DK
Insulin Resistance in HCV Infection
$121,674University Of California San Francisco · K23 · FY2004 · DK
Antihypertensive Effect of Food-Origin Isothiocyanate Soluble Epoxide Hydrolase Inhibitors
$121,645Fawzy Elbarbry · Pacific University · R16 · FY2022 · GM
OMEGA-3 FISH OIL SUPPLEMENTS VERSUS PLACEBO IN NON-ALCOHOLIC STEATOHEPATITIS
$121,613Stephen H Caldwell · University Of Virginia · M01 · FY2010 · RR
Core-005: Training Core
$121,274Pamela L Mellon · University Of California, San Diego · P42 · FY2017 · ES
Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD
$121,125Monika Sarkar · University Of California, San Francisco · R03 · FY2023 · DK
Pathophysiological sub-typing of pediatric type 2 diabetes based on clinical and genetic clustering methods
$121,125Shylaja Srinivasan · University Of California, San Francisco · R03 · FY2024 · DK
Ceramide, AMPK, and YAP/TAZ Signaling in Hepatic Fibrogenesis
$121,125Jennifer Y. Chen · University Of California, San Francisco · R03 · FY2022 · DK
Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD
$121,125Monika Sarkar · University Of California, San Francisco · R03 · FY2022 · DK
Ceramide, AMPK, and YAP/TAZ Signaling in Hepatic Fibrogenesis
$121,125Jennifer Y. Chen · University Of California, San Francisco · R03 · FY2023 · DK
Pathophysiological sub-typing of pediatric type 2 diabetes based on clinical and genetic clustering methods
$121,125Shylaja Srinivasan · University Of California, San Francisco · R03 · FY2025 · DK
Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
$121,087Mark J. Czaja · Albert Einstein College Of Medicine, Inc · R01 · FY2015 · DK
Niemann-Pick C liver-specific proteostasis and pathology
$121,022Mark Louis Schultz · University Of Michigan At Ann Arbor · K01 · FY2021 · DK